Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Short-term Investments (2016 - 2019)

Macrogenics (MGNX) has disclosed Short-term Investments for 5 consecutive years, with $89.3 million as the latest value for Q4 2019.

  • Quarterly Short-term Investments rose 601.09% to $89.3 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $89.3 million through Dec 2019, up 601.09% year-over-year, with the annual reading at $89.3 million for FY2019, 601.09% up from the prior year.
  • Short-term Investments for Q4 2019 was $89.3 million at Macrogenics, up from $12.7 million in the prior quarter.
  • The five-year high for Short-term Investments was $192.9 million in Q4 2016, with the low at $12.7 million in Q4 2018.
  • Average Short-term Investments over 5 years is $106.2 million, with a median of $93.4 million recorded in 2017.
  • The sharpest move saw Short-term Investments tumbled 86.36% in 2018, then skyrocketed 601.09% in 2019.
  • Over 5 years, Short-term Investments stood at $142.9 million in 2015, then surged by 35.01% to $192.9 million in 2016, then crashed by 51.58% to $93.4 million in 2017, then crashed by 86.36% to $12.7 million in 2018, then surged by 601.09% to $89.3 million in 2019.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $89.3 million, $12.7 million, and $93.4 million for Q4 2019, Q4 2018, and Q4 2017 respectively.